I-Corps at the NIH: Evidence-based Translational Medicine
Steve Blank
DECEMBER 17, 2014
If you’ve received this post in an email the embedded videos and powerpoint are best viewed on www.steveblank.com. With that SBIR-Phase 1 funding the teams were trying to establish the technical merit, feasibility, and commercial potential of their technology. This has been of tremendous value to us. Lessons Learned.
Let's personalize your content